Using Bayesian hierarchical models for controlled post hoc subgroup analysis of clinical trials: application to smoking cessation treatment in American Indians and Alaska Natives

References

• Berry, S. M., K. R. Broglio, S. Groshen, and D. A. Berry. 2013. Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials. Clin Trials 10 (5):720–734. doi:10.1177/1740774513497539.
   PubMed Web of Science ®Google Scholar
• Berry, S. M., B. P. Carlin, J. J. Lee, and P. Muller. 2010. Bayesian Adaptive Methods for Clinical Trials. CRC Press). doi:10.1201/EBK1439825488.
   Google Scholar
• Brookes, S. T., E. Whitely, M. Egger, G. D. Smith, P. A. Mulheran, and T. J. Peters. 2004. Subgroup analyses in randomized trials: Risks of subgroup-specific analyses; power and sample size for the interaction test. Journal of Clinical Epidemiology 57 (3):229–236. doi:10.1016/j.jclinepi.2003.08.009.
   PubMed Web of Science ®Google Scholar
• Chen, N., and J. J. Lee. 2019. Bayesian hierarchical classification and information sharing for clinical trials with subgroups and binary outcomes. Biometrical Journal Biometrische Zeitschrift 61 (5):1219–1231. doi:10.1002/bimj.201700275.
   PubMed Web of Science ®Google Scholar
• Daley, C. M., S. M. Daley, C. M. Pacheco, T. Edward Smith, M. Talawyma, C. McCloskey, W. S. Choi, N. Nazir, M. K. Filippi, D. McKinney, et al. 2018. Feasibility of implementing the all nations breath of life culturally tailored smoking cessation program for American Indians in multi-tribal urban communities. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco 20 (5):552–560. doi:10.1093/ntr/ntx030.
   PubMed Web of Science ®Google Scholar
• Daley, C. M., B. Faseru, N. Nazir, C. Solomon, K. A. Greiner, J. S. Ahluwalia, and W. S. Choi. 2011. Influence of traditional tobacco use on smoking cessation among American Indians. Addiction 106 (5):1003–1009. doi:10.1111/j.1360-0443.2011.03391.x.
   PubMed Web of Science ®Google Scholar
• Debra, S., J. Russo, D. L. LaVallie, and D. Buchwald. 2013. Barriers to cancer clinical trial participation among American Indian and Alaska Native tribal college students. The Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association 29 (1):55–60. doi:10.1111/j.1748-0361.2012.00432.x.
   PubMed Web of Science ®Google Scholar
• Faseru, B., E. F. Ellerbeck, D. Catley, B. J. Gajewski, T. S. Scheuermann, T. I. Shireman, L. M. Mussulman, N. Nazir, T. Bush, and K. P. Richter. 2017. Changing the default for tobacco-cessation treatment in an inpatient setting: Study protocol of a randomized controlled trial. Trials 18 (1):379–79. doi:10.1186/s13063-017-2119-9.
   PubMedGoogle Scholar
• Faseru, B., L. M. Mussulman, N. Nazir, E. F. Ellerbeck, E. Shergina, T. S. Scheuermann, B. J. Gajewski, D. Catley, and K. P. Richter. 2022. Use of pre-enrollment randomization and delayed consent to maximize participation in a clinical trial of opt-in versus opt-out tobacco treatment. Substance Abuse: Official Publication of the Association for Medical Education & Research in Substance Abuse 43 (1):1035–1042. doi:10.1080/08897077.2022.2060441.
   PubMed Web of Science ®Google Scholar
• Faseru, B., N. L. Nollen, M. S. Mayo, R. Krebill, W. S. Choi, N. L. Benowitz, R. F. Tyndale, K. S. Okuyemi, J. S. Ahluwalia, and L. Sanderson Cox. 2013. Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial. Addictive Behaviors 38 (3):1796–1803. doi:10.1016/j.addbeh.2012.11.010.
   PubMed Web of Science ®Google Scholar
• FDA. 2014. FDA action plan to enhance the collection and availability of demographic subgroup data. In 35.
   Google Scholar
• Freidlin, B., and E. L. Korn. 2013. Borrowing information across subgroups in phase II trials: Is it useful? Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 19 (6):1326–1334. doi:10.1158/1078-0432.CCR-12-1223.
   PubMed Web of Science ®Google Scholar
• Gandhi, K. K., J. Foulds, M. B. Steinberg, S.-E. Lu, and J. M. Williams. 2009. Lower quit rates among African American and Latino menthol cigarette smokers at a tobacco treatment clinic. International Journal of Clinical Practice 63 (3):360–367. doi:10.1111/j.1742-1241.2008.01969.x.
   PubMed Web of Science ®Google Scholar
• Ganggang, X., H. Zhu, and J. Jack Lee. 2020. Borrowing strength and borrowing index for bayesian hierarchical models. Computational Statistics & Data Analysis 144:106901. doi:10.1016/j.csda.2019.106901.
   PubMed Web of Science ®Google Scholar
• Gelman, A. 2006. Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper)’. Bayesian Analysis 1 (3):515–34, 20. doi:10.1214/06-BA117A.
   Web of Science ®Google Scholar
• Gelman, A., J. Hill, and M. Yajima. 2012. Why We (Usually) don’t have to worry about multiple comparisons. Journal of Research on Educational Effectiveness 5 (2):189–211. doi:10.1080/19345747.2011.618213.
   Web of Science ®Google Scholar
• Gene, P., and R. Mark. 2018. Bayesian Subgroup Analysis with Hierarchical Models.’. In Biopharmaceutical Applied Statistics Symposium : Volume 2 Biostatistical Analysis of Clinical Trials, ed. K. E. Peace, D.-G. Chen, and S. Menon, pp. 175–192. Singapore): Springer Singapore. doi:10.1007/978-981-10-7826-2_10
   Google Scholar
• Hartmann-Boyce, J., S. C. Chepkin, W. Ye, C. Bullen, and T. Lancaster. 2018. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev 5 (1): CD000146. doi:10.1002/14651858.CD000146.pub5.
   PubMedGoogle Scholar
• Henderson, N. C., T. A. Louis, C. Wang, and R. Varadhan. 2016. Bayesian analysis of heterogeneous treatment effects for patient-centered outcomes research. Health Services & Outcomes Research Methodology 16 (4):213–233. doi:10.1007/s10742-016-0159-3.
   PubMedGoogle Scholar
• Jamal, A., I. T. Agaku, E. O’Connor, B. A. King, J. B. Kenemer, and L. Neff. 2014. Current cigarette smoking among adults–United States, 2005-2013’. MMWR Morbidity and Mortality Weekly Report 63 (47):1108–1112.
   PubMed Web of Science ®Google Scholar
• Orr, M. F., E. Burduli, K. A. Hirchak, J. Ann Walsh Dotson, S. L. Young, L. Nelson, E. Lennstrom, T. Slaney, T. Bush, S. R. Gillaspy, et al. 2019. Culturally-tailored text-messaging intervention for smoking cessation in rural American Indian communities: Rationale, design, and methods. Contemporary Clinical Trials Communications 15:100363. doi:10.1016/j.conctc.2019.100363.
   PubMed Web of Science ®Google Scholar
• Richter, K. 2016. Changing the Default for Tobacco Treatment. University of Kansas Medical Center: National Institute of Health.
   Google Scholar
• Richter, K. P., D. Catley, B. J. Gajewski, B. Faseru, T. I. Shireman, C. Zhang, T. S. Scheuermann, L. M. Mussulman, N. Nazir, T. Hutcheson, et al. 2023. The effects of opt-out vs opt-in tobacco treatment on engagement, cessation, and costs: a randomized clinical trial. JAMA Internal Medicine 183 (4):331. doi:10.1001/jamainternmed.2022.7170.
   PubMed Web of Science ®Google Scholar
• Rothwell, P. M. 2005. Treating individuals 2. Subgroup analysis in randomised controlled trials: Importance, indications, and interpretation. The Lancet 365 (9454):176–186. doi:10.1016/S0140-6736(05)17709-5.
   PubMed Web of Science ®Google Scholar
• Schühlen, H. 2014. Pre-specified vs. post-hoc subgroup analyses: Are we wiser before or after a trial has been performed?’. European Heart Journal 35 (31):2055–2057. doi:10.1093/eurheartj/ehu202.
   PubMed Web of Science ®Google Scholar
• Smith, S. S., L. M. Rouse, M. Caskey, J. Fossum, J. K. C. Rick Strickland, J. Waukau, and J. Waukau. 2014. Culturally-Tailored Smoking Cessation for Adult American Indian Smokers: A Clinical Trial. The Counseling Psychologist 42 (6):852–886. doi:10.1177/0011000014542601.
   PubMed Web of Science ®Google Scholar
• U.S. Public Health Service Office of the Surgeon, General, Prevention National Center for Chronic Disease, Smoking Health Promotion Office on, and Health. 2020. ‘Publications and Reports of the Surgeon General.’ in, SmokingCessation: A Report of the Surgeon General (US Department of Health and Human Services: Washington (DC)).
   Google Scholar
• Yusuf, S., J. Wittes, J. Probstfield, and H. A. Tyroler. 1991. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 266 (1):93–98. doi:10.1001/jama.1991.03470010097038.
   PubMed Web of Science ®Google Scholar
• Yu-Yi, H., J. Zalkikar, and R. C. Tiwari. 2017. Hierarchical Bayes approach for subgroup analysis. Statistical Methods in Medical Research 28 (1):275–288. doi:10.1177/0962280217721782.
   PubMed Web of Science ®Google Scholar